Symposium
A dedicated symposium on EGFR mutations in NSCLC, featuring updates on third-generation TKIs and resistance mechanisms.
October 1, 2026
October 2, 2026
Medical Education Hall, Example City, Example Country
Symposium
Optimal strategies for EGFR testing in NSCLC.
Osimertinib and emerging EGFR inhibitors.
How EGFR resistance develops and how to overcome it.